Ann-Charlotte Kristoffersson
1 – 41 of 41
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Arginase release in hemolytic uremic syndrome affects the vasculature
2023) 11th VTEC International Symposium on Shiga Toxin (Verocytotoxin) Producing Escherichia coli Infections(
- Contribution to conference › Abstract
-
Mark
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome
(
- Contribution to journal › Article
-
Mark
Genetic investigation of Nordic patients with complement-mediated kidney diseases
(
- Contribution to journal › Article
- 2022
-
Mark
IgG Binds Escherichia coli Serine Protease EspP and Protects Mice From E. coli O157:H7 Infection
(
- Contribution to journal › Article
-
Mark
Apyrase decreases phage induction and Shiga toxin release from E. coli O157:H7 and has a protective effect during infection
(
- Contribution to journal › Article
- 2021
-
Mark
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
(
- Contribution to journal › Article
- 2020
-
Mark
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
(
- Contribution to journal › Article
- 2019
-
Mark
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism
(
- Contribution to journal › Article
-
Mark
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
(
- Contribution to journal › Article
- 2018
-
Mark
Aliskiren inhibits renin-mediated complement activation
(
- Contribution to journal › Article
- 2017
-
Mark
Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney
(
- Contribution to journal › Scientific review
-
Mark
C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
(
- Contribution to journal › Article
- 2016
-
Mark
Early terminal complement blockade and C6 deficiency are protective in enterohemorrhagic Escherichia coli-infected mice
(
- Contribution to journal › Article
- 2015
-
Mark
Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles.
(
- Contribution to journal › Article
- 2014
-
Mark
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy.
(
- Contribution to journal › Article
- 2013
-
Mark
Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
(
- Contribution to journal › Article
-
Mark
Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy.
(
- Contribution to journal › Article
- 2012
-
Mark
A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
(
- Contribution to journal › Article
-
Mark
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis
(
- Contribution to journal › Article
-
Mark
Intestinal damage in enterohemorrhagic Escherichia coli infection.
(
- Contribution to journal › Article
-
Mark
IgA nephropathy associated with a novel N-terminal mutation in factor H.
(
- Contribution to journal › Article
- 2010
-
Mark
Intestinal Damage in Enterohemorrhagic Escherichia coli (EHEC) Infection
2010) 15th Congress of the International Pediatric Nephrology Association In Pediatric Nephrology 25(9). p.1834-1834(
- Contribution to journal › Published meeting abstract
-
Mark
ADAMTS13 Expression in Glomerular Endothelial Cells
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
A novel mutation in the complement regulator clusterin in recurrent haemolytic uraemic syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
-
Mark
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
(
- Contribution to journal › Article
-
Mark
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients.
(
- Contribution to journal › Article
- 2007
-
Mark
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
(
- Contribution to journal › Article
-
Mark
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
-
Mark
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
(
- Contribution to journal › Article
- 2006
-
Mark
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Platelet activation in hemolytic uremic syndrome.
(
- Contribution to journal › Scientific review
- 2005
-
Mark
VWF-cleaving protease (ADAMTS13) in premature infants.
(
- Contribution to journal › Article
- 1996
-
Mark
Recurrent mutation Asn45-->Ser of glycoprotein IX in Bernard-Soulier syndrome
(
- Contribution to journal › Letter
- 1980
-
Mark
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX
(
- Contribution to journal › Article